Durex nixes nonoxynol-9
This article was originally published in The Tan Sheet
Executive Summary
Condom marketer will discontinue the use of the spermicide nonoxynol-9 in manufacturing its Durex condom line due to an anticipated "material reduction in demand for spermicidally lubricated condoms," SSL International announces recently. The decision follows a report by the World Health Organization "which questioned the level of additional protection provided by such condoms when compared to non-spermicidally lubricated condoms," London-based company says. The WHO's June 2002 report also recommended evaluating the safety of spermicides following research that showed their use may increase the risk of STD transmission (1"The Tan Sheet" July 8, 2002, p. 17)...
You may also be interested in...
N-9 Data Warrants Spermicide Safety Study, WHO Report Recommends
The safety of all spermicides should be evaluated in light of recent research indicating the one-time top microbicide candidate nonoxynol-9 actually causes lesions that may facilitate transmission of HIV and other sexually transmitted infections, according to the final report of a "Technical Consultation on N-9," released June 25
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.